Correction: Brusatol ameliorates psoriatic dyslipidemia by targeting IL-1β to restore AMPK-mediated lipid homeostasis
Yuankuan Jiang, Shumeng Zhang, Hewen Guan, Kejia lv, Jinchao Yu, Siyi Li, Renchuan Jia, Xiujie Zhang, Shurong Ma, Jialin Qu, Jingrong Lin · 2026
Read Correction: Brusatol ameliorates psoriatic dyslipidemia by targeting IL-1β to restore AMPK-mediated lipid homeostasis by Yuankuan Jiang, Shumeng Zhang, Hewen Guan, Kejia lv, Jinchao Yu, Siyi Li, Renchuan Jia, Xiujie Zhang, Shurong Ma, Jialin Qu, Jingrong Lin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13523190.txt.
Description
ells treated with brusatol (40 nM and 80 nM) in Fig. 5A were inadvertently duplicated. Brusatol suppresses lipid synthesis and accumulation in vitro and in vivo. A Representative Oil Red O-stained HepG2 cells induced with oleic acid (OA, 100 μM) and treated with Brusatol (40, 80, 160 nM) for 24 h.
Catalog record
| CREATOR | Yuankuan Jiang, Shumeng Zhang, Hewen Guan, Kejia lv, Jinchao Yu, Siyi Li, Renchuan Jia, Xiujie Zhang, Shurong Ma, Jialin Qu, Jingrong Lin |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |